Cargando…
The ideal treatment timing for diabetic retinopathy: the molecular pathological mechanisms underlying early-stage diabetic retinopathy are a matter of concern
Diabetic retinopathy (DR) is a prevalent complication of diabetes, significantly impacting patients’ quality of life due to vision loss. No pharmacological therapies are currently approved for DR, excepted the drugs to treat diabetic macular edema such as the anti-VEGF agents or steroids administere...
Autores principales: | Sun, Wen-Jie, An, Xue-Dong, Zhang, Yue-Hong, Zhao, Xue-Fei, Sun, Yu-Ting, Yang, Cun-Qing, Kang, Xiao-Min, Jiang, Lin-Lin, Ji, Hang-Yu, Lian, Feng-Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680169/ https://www.ncbi.nlm.nih.gov/pubmed/38027131 http://dx.doi.org/10.3389/fendo.2023.1270145 |
Ejemplares similares
-
Klotho’s impact on diabetic nephropathy and its emerging connection to diabetic retinopathy
por: Tang, Anqi, et al.
Publicado: (2023) -
Endothelial Dysfunction in Diabetic Retinopathy
por: Gui, Fu, et al.
Publicado: (2020) -
Research progress on exosomes/microRNAs in the treatment of diabetic retinopathy
por: Niu, Si-ru, et al.
Publicado: (2022) -
A Hypothesis From Metabolomics Analysis of Diabetic Retinopathy: Arginine-Creatine Metabolic Pathway May Be a New Treatment Strategy for Diabetic Retinopathy
por: Sun, Ye, et al.
Publicado: (2022) -
Plasma Metabolomics Reveals Metabolic Profiling For Diabetic Retinopathy and Disease Progression
por: Sun, Yu, et al.
Publicado: (2021)